LFVN Form DEFA14A: Additional definitive proxy soliciting materials

LIFEVANTAGE CORP Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-09-18: Form DEFA14A; Description DEFA14A; Document lfvn_defa_14a.htm.
2025-09-19: Form DEFA14A; Description DEFA14A; Document defa14a-fy26proxy.htm.
2024-09-20: Form DEFA14A; Description DEFA14A; Document defa14a-fy25proxy.htm.
2023-10-30: Form DEFA14A; Description DEFA14A; Document defa14a-fifeletter.htm.

Filed	Form	Description	Document
2026-09-18	DEFA14A	DEFA14A	lfvn_defa_14a.htm
2025-09-19	DEFA14A	DEFA14A	defa14a-fy26proxy.htm
2024-09-20	DEFA14A	DEFA14A	defa14a-fy25proxy.htm
2023-10-30	DEFA14A	DEFA14A	defa14a-fifeletter.htm
2023-10-25	DEFA14A	DEFA14A	defa14a-rebuttalpr.htm
2023-10-18	DEFA14A	DEFA14A	defa14a-stockperformancegr.htm
2023-10-16	DEFA14A	DEFA14A	defa14a-investordeckpressr.htm
2023-10-16	DEFA14A	DEFA14A	defa14a-investorpresentati.htm
2023-10-13	DEFA14A	DEFA14A	defa14a-ceoletter.htm
2023-10-10	DEFA14A	DEFA14A	defa14a-phonescript.htm
2023-10-10	DEFA14A	DEFA14A	defa14a-conventionpr.htm
2023-10-05	DEFA14A	DEFA14A	defa14a-fy24proxyletter2.htm
2023-10-02	DEFA14A	DEFA14A	defa14a-fy24proxyxsuppleme.htm
2023-09-25	DEFA14A	DEFA14A	defa14a-fy24proxy.htm
2023-08-14	DEFA14A	DEFA14A	defa14a-radoffnominationno.htm
2022-09-30	DEFA14A	DEFA14A	defa14a-fy23proxy.htm
2021-09-30	DEFA14A	DEFA14A	defa14a-fy22proxy.htm
2020-11-04	DEFA14A	DEFA14A	defa14a-fy21proxysupplement.htm
2020-09-30	DEFA14A	DEFA14A	defa14a-fy21proxy.htm
2019-11-26	DEFA14A	DEFA14A	defa14areminderletter2019p.htm
2019-10-18	DEFA14A	DEFA14A	defa14a-fy2019.htm
2018-09-28	DEFA14A	DEFA14A	defa14a-fy2019.htm
2018-01-26	DEFA14A	DEFA14A	lfvn_defa141a.htm
2018-01-23	DEFA14A	DEFA14A	amendedproxystatementfy2018.htm
2017-12-20	DEFA14A	DEFA14A	defa14a-fy2018.htm
2017-02-03	DEFA14A	DEFA14A	lfvndefa14a.htm
2015-09-02	DEFA14A	DEFA14A	solicitationforproxy.htm
2012-11-06	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	d433979ddefa14a.htm

Stock Name	Country	Market Cap	PE Ratio
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Valion Bio, Inc. (VBIO)	United States	$0.077B
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41